• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重与冠心病风险增加相关,部分独立于血压和胆固醇水平:对21项队列研究(涉及超过30万人)的荟萃分析

Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.

作者信息

Bogers Rik P, Bemelmans Wanda J E, Hoogenveen Rudolf T, Boshuizen Hendriek C, Woodward Mark, Knekt Paul, van Dam Rob M, Hu Frank B, Visscher Tommy L S, Menotti Alessandro, Thorpe Roland J, Jamrozik Konrad, Calling Susanna, Strand Bjørn Heine, Shipley Martin J

机构信息

Centre for Prevention and Health Services Research, National Institute for Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands.

出版信息

Arch Intern Med. 2007 Sep 10;167(16):1720-8. doi: 10.1001/archinte.167.16.1720.

DOI:10.1001/archinte.167.16.1720
PMID:17846390
Abstract

BACKGROUND

The extent to which moderate overweight (body mass index [BMI], 25.0-29.9 [calculated as weight in kilograms divided by height in meters squared]) and obesity (BMI, >/= 30.0) are associated with increased risk of coronary heart disease (CHD) through adverse effects on blood pressure and cholesterol levels is unclear, as is the risk of CHD that remains after these mediating effects are considered.

METHODS

Relative risks (RRs) of CHD associated with moderate overweight and obesity with and without adjustment for blood pressure and cholesterol concentrations were calculated by the members of a collaboration of prospective cohort studies of healthy, mainly white persons and pooled by means of random-effects models (RRs for categories of BMI in 14 cohorts and for continuous BMI in 21 cohorts; total N = 302 296).

RESULTS

A total of 18 000 CHD events occurred during follow-up. The age-, sex-, physical activity-, and smoking-adjusted RRs (95% confidence intervals) for moderate overweight and obesity compared with normal weight were 1.32 (1.24-1.40) and 1.81 (1.56-2.10), respectively. Additional adjustment for blood pressure and cholesterol levels reduced the RR to 1.17 (1.11-1.23) for moderate overweight and to 1.49 (1.32-1.67) for obesity. The RR associated with a 5-unit BMI increment was 1.29 (1.22-1.35) before and 1.16 (1.11-1.21) after adjustment for blood pressure and cholesterol levels.

CONCLUSIONS

Adverse effects of overweight on blood pressure and cholesterol levels could account for about 45% of the increased risk of CHD. Even for moderate overweight, there is a significant increased risk of CHD independent of these traditional risk factors, although confounding (eg, by dietary factors) cannot be completely ruled out.

摘要

背景

中度超重(体重指数[BMI],25.0 - 29.9[计算方法为体重(千克)除以身高(米)的平方])和肥胖(BMI,≥30.0)通过对血压和胆固醇水平产生不利影响而与冠心病(CHD)风险增加相关的程度尚不清楚,在考虑这些中介作用后仍存在的冠心病风险也不明确。

方法

由一项针对健康的、主要为白人的前瞻性队列研究合作项目的成员计算出与中度超重和肥胖相关的冠心病相对风险(RRs),计算时分别调整和未调整血压及胆固醇浓度,并通过随机效应模型进行汇总(14个队列中BMI分类的RRs以及21个队列中连续BMI的RRs;总样本量N = 302296)。

结果

随访期间共发生18000例冠心病事件。与正常体重相比,经年龄、性别、体力活动和吸烟调整后的中度超重和肥胖的RRs(95%置信区间)分别为1.32(1.24 - 1.40)和1.81(1.56 - 2.10)。进一步调整血压和胆固醇水平后,中度超重的RR降至1.17(1.11 - 1.23),肥胖的RR降至1.49(1.32 - 1.67)。在调整血压和胆固醇水平之前,与BMI增加5个单位相关的RR为1.29(1.22 - 1.35),调整后为1.16(1.11 - 1.21)。

结论

超重对血压和胆固醇水平的不利影响可能占冠心病风险增加的约45%。即使是中度超重,独立于这些传统风险因素之外,冠心病风险也显著增加,尽管不能完全排除混杂因素(如饮食因素)的影响。

相似文献

1
Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.超重与冠心病风险增加相关,部分独立于血压和胆固醇水平:对21项队列研究(涉及超过30万人)的荟萃分析
Arch Intern Med. 2007 Sep 10;167(16):1720-8. doi: 10.1001/archinte.167.16.1720.
2
Influence of calendar period on the association between BMI and coronary heart disease: a meta-analysis of 31 cohorts.BMI 与冠心病相关性的时间趋势:31 项队列研究的荟萃分析
Obesity (Silver Spring). 2013 May;21(5):865-80. doi: 10.1002/oby.20043.
3
Obesity in 70-year-old subjects as a risk factor for 15-year coronary heart disease incidence.70岁人群中的肥胖是15年冠心病发病率的一个风险因素。
Obes Res. 2003 Jul;11(7):817-27. doi: 10.1038/oby.2003.113.
4
Estimated risk of coronary heart disease in obese adult males in Northern Jordan.约旦北部肥胖成年男性患冠心病的估计风险。
Saudi Med J. 2006 May;27(5):681-6.
5
Prediction of first events of coronary heart disease and stroke with consideration of adiposity.考虑肥胖因素对冠心病和中风首发事件的预测
Circulation. 2008 Jul 8;118(2):124-30. doi: 10.1161/CIRCULATIONAHA.108.772962.
6
Relationship between obesity and cardiovascular risk factors: findings from a multi-state screening project in the United States.肥胖与心血管危险因素之间的关系:美国一项多州筛查项目的研究结果
Curr Med Res Opin. 2005 Nov;21(11):1755-61. doi: 10.1185/030079905X65231.
7
The associations between current recommendation for physical activity and cardiovascular risks associated with obesity.当前身体活动建议与肥胖相关心血管风险之间的关联。
Eur J Clin Nutr. 2008 Jan;62(1):1-9. doi: 10.1038/sj.ejcn.1602693. Epub 2007 Mar 7.
8
Co-occurrence of metabolic factors and the risk of coronary heart disease: a prospective cohort study in the Netherlands.代谢因素的共同发生与冠心病风险:荷兰的前瞻性队列研究。
Int J Cardiol. 2012 Mar 8;155(2):223-9. doi: 10.1016/j.ijcard.2010.09.047. Epub 2010 Oct 20.
9
Obesity and disease management: effects of weight loss on comorbid conditions.肥胖与疾病管理:体重减轻对合并症的影响。
Obes Res. 2001 Nov;9 Suppl 4:326S-334S. doi: 10.1038/oby.2001.138.
10
Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study.心血管危险因素与蛋白尿发生之间的直接、渐进性关联:韩国医疗保险机构(KMIC)研究结果
Arch Intern Med. 2005 Oct 24;165(19):2299-304. doi: 10.1001/archinte.165.19.2299.

引用本文的文献

1
Characterization and risk stratification of coronary artery disease in people living with HIV: a global systematic review.HIV感染者冠状动脉疾病的特征与风险分层:一项全球系统评价
Front Cardiovasc Med. 2025 Aug 12;12:1586019. doi: 10.3389/fcvm.2025.1586019. eCollection 2025.
2
Obesity, Dietary Patterns, and Cardiovascular Disease: A Narrative Review of Metabolic and Molecular Pathways.肥胖、饮食模式与心血管疾病:代谢和分子途径的叙述性综述
Curr Issues Mol Biol. 2025 Jun 10;47(6):440. doi: 10.3390/cimb47060440.
3
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.
胰高血糖素样肽-1受体激动剂在心肌梗死及降低动脉粥样硬化性心血管疾病风险中的应用:治疗所需人数、疗效及安全性的综合荟萃分析
Cardiovasc Diabetol. 2025 Jul 12;24(1):285. doi: 10.1186/s12933-025-02840-3.
4
Hypertensive Disorders of Pregnancy, Preterm Delivery, and Infant Size: Which Mothers Have Highest Cardiovascular Disease Mortality?妊娠期高血压疾病、早产和婴儿大小:哪些母亲的心血管疾病死亡率最高?
Paediatr Perinat Epidemiol. 2025 Aug;39(6):515-523. doi: 10.1111/ppe.70033. Epub 2025 Jun 5.
5
Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review.当前及新出现的用于减肥的胃肠外和口服药物:一项叙述性综述
Diseases. 2025 Apr 22;13(5):129. doi: 10.3390/diseases13050129.
6
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS.马昔腾坦与他达拉非联合治疗肺动脉高压合并心血管疾病患者:来自OPUS和OrPHeUS的真实世界证据
Adv Ther. 2025 May 19. doi: 10.1007/s12325-025-03180-0.
7
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
8
Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective.胰高血糖素样肽-1受体激动剂:心血管视角的综述
Front Cardiovasc Med. 2025 Apr 24;12:1535134. doi: 10.3389/fcvm.2025.1535134. eCollection 2025.
9
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC.心力衰竭与肥胖:转化方法与治疗前景。欧洲心脏病学会心力衰竭协会的科学声明。
Eur J Heart Fail. 2025 Jul;27(7):1273-1293. doi: 10.1002/ejhf.3676. Epub 2025 May 6.
10
Obesity and its management in primary care setting.肥胖症及其在基层医疗环境中的管理。
J Diabetes Complications. 2025 Jul;39(7):109045. doi: 10.1016/j.jdiacomp.2025.109045. Epub 2025 Apr 19.